Table 3.
Study | N Studiesa | N Patients | Pooled Success Rateb |
---|---|---|---|
MSSA PJI | 28 | 1381 | 60% |
MRSA PJI | 26 | 416 | 58% |
Hip MSSA PJI | 2 | 32 | 81% |
Hip MRSA PJI | 1 | 12 | 92% |
Knee MSSA PJI | 3 | 56 | 66% |
Knee MRSA PJI | 3 | 78 | 64% |
Abbreviations: DAIR, debridement, antibiotics, and retention of the implant; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; PJI, prosthetic joint infection.
aPer category, studies were included if they reported specific or combined outcome for hip and/or knee MSSA and MRSA.
bBased on individual patient data.